Your browser doesn't support javascript.
loading
Editorial Comment: Secondary polycythemia in men receiving testosterone therapy increases risk of major adverse cardiovascular events and venous thromboembolism in the first year of therapy.
Barros, Rodrigo.
Affiliation
  • Barros R; Serviço de Urologia, Hospital Universitário Antônio Pedro - Universidade Federal Fluminense - UFF, Niterói, RJ, Brasil.
Int Braz J Urol ; 49(1): 150-151, 2023.
Article in En | MEDLINE | ID: mdl-36512463
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polycythemia / Venous Thromboembolism / Hypogonadism Type of study: Etiology_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Int Braz J Urol Journal subject: UROLOGIA Year: 2023 Document type: Article Affiliation country: Brazil Country of publication: Brazil
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polycythemia / Venous Thromboembolism / Hypogonadism Type of study: Etiology_studies / Risk_factors_studies Limits: Humans / Male Language: En Journal: Int Braz J Urol Journal subject: UROLOGIA Year: 2023 Document type: Article Affiliation country: Brazil Country of publication: Brazil